Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01868451 |
|---|---|
| Brief Title: | Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma |
| First Submitted : | May 30, 2013 |
| First Submitted that Met QC Criteria : | May 30, 2013 |
| First Posted : | June 4, 2013 (Estimate) |
| Last Update Submitted that Met QC Criteria : | July 28, 2020 |
| Last Update Posted : | July 29, 2020 |